Heath E M, Wilcox A R, Quinn C M
Department of Exercise and Sport Science, Oregon State University, Corvallis 97331.
Med Sci Sports Exerc. 1993 Sep;25(9):1018-23.
The purpose of this study was to investigate the effects of pharmacologic treatment with nicotinic acid (NA) (3 g NA.d-1) on fuel utilization during exercise and on total and HDL-cholesterol levels of trained runners. Eight experienced male runners performed four 30-min submaximal treadmill runs (SUB) at approximately 60% of aerobic capacity: the first served as the control condition, whereas SUBs 2, 3, and 4 were conducted at the onset, midpoint, and conclusion of the 3-wk NA treatment period. A 1-g NA dose was ingested 1 h prior to SUBs 2-4, which were conducted in the morning following a 12-h fast. The respiratory exchange ratio (RER) was significantly higher during SUBs 2, 3, and 4 (0.919 +/- 0.009, 0.898 +/- 0.007, and 0.896 +/- 0.009, respectively) than during SUB1 (0.871 +/- 0.008); and the RER during SUB2 was also significantly higher than that during SUB3 and SUB4 (P < 0.001). Serum free fatty acid (FFA) and glycerol levels were significantly lower during SUBs 2, 3, and 4 as compared with SUB1 (P < 0.001). Total cholesterol showed a significant decrease (from 195.3 +/- 9.2 to 174.5 +/- 9.2 mg.dl-1) and HDL cholesterol showed a significant elevation (from 56.2 +/- 2.9 to 63.0 +/- 3.9 mg.dl-1) during the NA treatment period (P < 0.05). The RER, FFA, and glycerol data demonstrate a persistent inhibition of fat utilization during submaximal exercise due to NA treatment. The 3-wk NA treatment period also proved to be sufficient to effect changes in total and HDL-cholesterol levels of these runners.
本研究的目的是调查烟碱酸(NA)(3克NA·天-1)药物治疗对训练有素的跑步者运动期间燃料利用以及总胆固醇和高密度脂蛋白胆固醇水平的影响。八名经验丰富的男性跑步者以约60%的有氧能力进行了四次30分钟的亚极量跑步机跑步(SUB):第一次作为对照条件,而SUB 2、3和4分别在3周NA治疗期的开始、中点和结束时进行。在SUB 2-4前1小时摄入1克NA剂量,这些测试在禁食12小时后的早晨进行。与SUB1期间(0.871±0.008)相比,SUB 2、3和4期间的呼吸交换率(RER)显著更高(分别为0.919±0.009、0.898±0.007和0.896±0.009);SUB2期间的RER也显著高于SUB3和SUB4期间(P<0.001)。与SUB1相比,SUB 2、3和4期间血清游离脂肪酸(FFA)和甘油水平显著降低(P<0.001)。在NA治疗期间,总胆固醇显著降低(从195.3±9.2降至174.5±9.2毫克·分升-1),高密度脂蛋白胆固醇显著升高(从56.2±2.9升至63.0±3.9毫克·分升-1)(P<0.05))。RER、FFA和甘油数据表明,由于NA治疗,亚极量运动期间脂肪利用持续受到抑制。3周的NA治疗期也被证明足以影响这些跑步者的总胆固醇和高密度脂蛋白胆固醇水平。